FHA
FLGT icon

First Horizon Advisors’s Fulgent Genetics FLGT Stock Holding History

First Horizon Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19
Closed -$508 – 2394
2023
Q3 		$508 Hold
19
– – ﹤0.01% 2310
2023
Q2 		$703 Hold
19
– – ﹤0.01% 2335
2023
Q1 		$593 Hold
19
– – ﹤0.01% 2374
2022
Q4 		$565 Buy
+19
New +$680 ﹤0.01% 2364

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Horizon Advisors's FLGT Position: Q4 2023 in Review

First Horizon Advisors sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 19 shares — an estimated $508 sold.

First Horizon Advisors first reported a position in FLGT in Q4 2022 and held it in 4 quarters. The position peaked at $703 in Q2 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • First Horizon Advisors reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • First Horizon Advisors sold 19 Fulgent Genetics shares in Q4 2023, an estimated $508.
  • First Horizon Advisors first reported a position in Fulgent Genetics in Q4 2022 and held it in 4 quarters.
  • First Horizon Advisors's Fulgent Genetics position peaked at $703 in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on First Horizon Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.